Anyone undertaking "due diligence" will have access to a lot more info that us - they do not have to wait till the release of the formal scoping study.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025